Bio-Techne Corporation TECH

$ 51.48 -0.21%

Quarterly report 2025-Q4
added 02-04-2026

Bio-Techne Corporation DIO Ratio 2011-2026 | TECH

Annual DIO Ratio Bio-Techne Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
157	165	156	135	135	139	138	148	116	128	125	133	160	177	252

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
252	116	151

Quarterly DIO Ratio Bio-Techne Corporation

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
178	182	-	170	165	156	-	166	174	178	-	164	160	147	69	128	128	123	61.8	135	132	144	128	136	134	128	131	128	135	146	127	127	118	149	127	123	143	135	112	115	137	134	115	126	132	117	97.9	102	143	139	125	135	175	180	176	186	194	207	210	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
210	61.8	142

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Axsome Therapeutics AXSM	168	$ 156.92	-1.23 %	$ 7.81 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	BioMarin Pharmaceutical BMRN	644	$ 54.13	-1.64 %	$ 10.4 B	USA
	Coherus BioSciences CHRS	97.5	$ 1.52	-5.59 %	$ 178 M	USA
	Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA